What is the recommended N-acetylcysteine (NAC) infusion dose for pediatric patients with acetaminophen overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

N-acetylcysteine (NAC) Infusion Dosing for Pediatric Acetaminophen Overdose

The recommended N-acetylcysteine (NAC) infusion dose for pediatric patients with acetaminophen overdose is a total of 300 mg/kg administered intravenously as three sequential doses: 150 mg/kg loading dose over 15-60 minutes, followed by 50 mg/kg over 4 hours, and 100 mg/kg over 16 hours. 1

Standard Dosing Protocol

The FDA-approved intravenous NAC regimen for pediatric patients follows the same weight-based dosing as adults:

  1. Loading dose: 150 mg/kg over 15-60 minutes
  2. Second dose: 50 mg/kg over 4 hours
  3. Third dose: 100 mg/kg over 16 hours

This regimen delivers a total dose of 300 mg/kg over a 21-hour period. 2, 1

Administration Considerations

Dilution Requirements

NAC is hyperosmolar (2600 mOsmol/L) and must be diluted prior to administration. For pediatric patients, consider the following:

  • Dilute in sterile water for injection, 0.45% sodium chloride, or 5% dextrose in water 1
  • Adjust osmolarity to a physiologically safe level (generally not less than 150 mOsmol/L in pediatric patients) 1
  • Using 0.45% saline with 5% dextrose has been shown to be safe and effective in preventing symptomatic hyponatremia in children 3

Monitoring Requirements

  • Monitor for hypersensitivity reactions, which occur in 10-15% of patients 2
  • Check hepatic and renal function and electrolytes throughout treatment 1
  • Monitor acetaminophen levels, ALT/AST, and INR after the last maintenance dose 1

Alternative Regimens

Some centers have implemented alternative NAC regimens for pediatric patients:

  1. Two-stage infusion: 150 mg/kg bolus over 1 hour followed by a continuous infusion of 10 mg/kg/hour for 20 hours (total dose 350 mg/kg) 3

  2. Simplified regimen: 150 mg/kg loading dose followed by a maintenance infusion of 15 mg/kg/hour until termination criteria are met 4

These alternative regimens may reduce medication errors and improve patient safety by simplifying administration, but they are not FDA-approved. 4

Treatment Duration Considerations

  • Complete the full 21-hour treatment course if there is any uncertainty about the patient's risk of developing hepatotoxicity 1
  • Continue treatment beyond the initial protocol if:
    • Acetaminophen levels are still detectable
    • ALT/AST are still increasing
    • INR remains elevated 1

Special Considerations

  • For high-risk ingestions (acetaminophen levels >300 mg/L at 4 hours), the standard dose regimen is still effective when started within 8 hours of ingestion 5
  • Early administration of NAC (within 8 hours of ingestion) is the most critical factor in preventing morbidity and mortality 2
  • NAC treatment should be initiated immediately without waiting for serum acetaminophen determinations in cases of suspected significant overdose 2

Potential Adverse Effects

  • Hypersensitivity reactions (rash, hypotension, wheezing, shortness of breath)
  • Anaphylactoid reactions (3.4% in pediatric patients) 4
  • Use with caution in patients with asthma or history of bronchospasm 1

The standard 21-hour, three-dose regimen remains the most widely accepted protocol for pediatric acetaminophen overdose, with strong evidence supporting its efficacy and safety when administered properly.

References

Guideline

Acute Liver Failure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation of an Alternative Intravenous N-Acetylcysteine Regimen in Pediatric Patients.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.